Jazz Pharmaceuticals to Report 2020 Fourth Quarter Financial Results on February 23, 2021

On February 9, 2021 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) reported that it will report its 2020 fourth quarter and full year financial results on Tuesday, February 23, 2021, after the close of the financial markets (Press release, Jazz Pharmaceuticals, FEB 9, 2021, View Source [SID1234574816]). Company management will host a live audio webcast immediately following the announcement at 4:30 p.m. EST/9:30 p.m. GMT to discuss fourth quarter 2020 financial results and provide a business and financial update.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A replay of the conference call will be available through March 2, 2021, and accessible through one of the following telephone numbers, using the passcode below:

Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast will be archived on the website for at least one week.